Article info

Original research
Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients

Authors

  1. Correspondence to Dr Michael D Parkins, Department of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada; mdparkin{at}ucalgary.ca
View Full Text

Citation

Thornton CS, Waddell BJ, Congly SE, et al
Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients

Publication history

  • Received July 1, 2023
  • Accepted April 2, 2024
  • First published April 15, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.